Article Versions Notes

Rajkhowa B, Mehan S, Sethi P, Prajapati A, Suri M, Kumar S, Bhalla S, Narula AS, Alshammari A, Alharbi M, et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals. 2022; 15(8):959. https://doi.org/10.3390/ph15080959

Rajkhowa, Bidisha, Sidharth Mehan, Pranshul Sethi, Aradhana Prajapati, Manisha Suri, Sumit Kumar, Sonalika Bhalla, Acharan S. Narula, Abdulrahman Alshammari, Metab Alharbi, and et al. 2022. "Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder" Pharmaceuticals 15, no. 8: 959. https://doi.org/10.3390/ph15080959

Rajkhowa, B., Mehan, S., Sethi, P., Prajapati, A., Suri, M., Kumar, S., Bhalla, S., Narula, A. S., Alshammari, A., Alharbi, M., Alkahtani, N., Alghamdi, S., & Kalfin, R. (2022). Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals, 15(8), 959. https://doi.org/10.3390/ph15080959